Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Opioid-Related Disorders 1 Neoplasms 1 Lymphoma, Follicular 1 Cancer Pain 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

resiniferatoxin 1 Transcranial Direct Current Stimulation 1 Standard of Care 1 Patient Education as Topic 1 Passive Cutaneous Anaphylaxis 1 Morphine 1 Methadone 1 Infusions, Intravenous 1 Administration, Sublingual 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Cancer Pain × Methadone × Clear all

NCT05325164 2022-12-05

METHADOPT

Ottawa Hospital Research Institute

Phase 3 Withdrawn

Cancer Pain, Adenocarcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡